Robert Nathaniel Lande - Net Worth and Insider Trading
Robert Nathaniel Lande Net Worth
The estimated net worth of Robert Nathaniel Lande is at least $1 Million dollars as of 2024-09-14. Robert Nathaniel Lande is the Director of Knight Therapeutics Inc and owns about 243,178 shares of Knight Therapeutics Inc (TSX:GUD) stock worth over $1 Million. Details can be seen in Robert Nathaniel Lande's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Robert Nathaniel Lande has not made any transactions after 2024-05-29 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Robert Nathaniel Lande
Robert Nathaniel Lande Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Robert Nathaniel Lande owns 1 companies in total, including Knight Therapeutics Inc (TSX:GUD) .
Click here to see the complete history of Robert Nathaniel Lande’s form 4 insider trades.
Insider Ownership Summary of Robert Nathaniel Lande
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| TSX:GUD | Knight Therapeutics Inc | 2024-05-29 | Director |
Robert Nathaniel Lande Latest Holdings Summary
Robert Nathaniel Lande currently owns a total of 1 stock. Robert Nathaniel Lande owns 243,178 shares of Knight Therapeutics Inc (TSX:GUD) as of May 29, 2024, with a value of $1 Million.
Latest Holdings of Robert Nathaniel Lande
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| TSX:GUD | Knight Therapeutics Inc | 2024-05-29 | 243,178 | 5.98 | 1,454,204 |
Holding Weightings of Robert Nathaniel Lande
Robert Nathaniel Lande Form 4 Trading Tracker
According to the SEC Form 4 filings, Robert Nathaniel Lande has made a total of 23 transactions in Knight Therapeutics Inc (TSX:GUD) over the past 5 years, including 20 buys and 3 sells. The most-recent trade in Knight Therapeutics Inc is the sale of 15,000 shares on May 29, 2024, which brought Robert Nathaniel Lande around $88,601.
Insider Trading History of Robert Nathaniel Lande
- 1
Robert Nathaniel Lande Trading Performance
GuruFocus tracks the stock performance after each of Robert Nathaniel Lande's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Robert Nathaniel Lande is 1.67%. GuruFocus also compares Robert Nathaniel Lande's trading performance to market benchmark return within the same time period. The performance of stocks bought by Robert Nathaniel Lande within 3 months outperforms 16 times out of 21 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Robert Nathaniel Lande's insider trading performs compared to the benchmark.
Performance of Robert Nathaniel Lande
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 0.08 | | | | | |
| Relative Return to S&P 500(%) | 0.24 | | | | | |
Robert Nathaniel Lande Ownership Network
Robert Nathaniel Lande Owned Company Details
What does Knight Therapeutics Inc do?
Who are the key executives at Knight Therapeutics Inc?
Robert Nathaniel Lande is the Director of Knight Therapeutics Inc. Other key executives at Knight Therapeutics Inc include Senior Officer Amal Khouri , Director & Director or Senior Officer of 10% Security Holder Jonathan Ross Goodman , and 10% Security Holder Sime Armoyan .
Knight Therapeutics Inc (TSX:GUD) Insider Trades Summary
Over the past 18 months, Robert Nathaniel Lande made 3 insider transaction in Knight Therapeutics Inc (TSX:GUD) with a net sale of 45,000. Other recent insider transactions involving Knight Therapeutics Inc (TSX:GUD) include a net purchase of 1,479,900 shares made by Sime Armoyan , a net sale of 65,000 shares made by Amal Khouri , and a net purchase of 30,000 shares made by Jonathan Ross Goodman .
In summary, during the past 3 months, insiders sold 45,000 shares of Knight Therapeutics Inc (TSX:GUD) in total and bought 0 shares, with a net sale of 45,000 shares. During the past 18 months, 314,200 shares of Knight Therapeutics Inc (TSX:GUD) were sold and 1,734,100 shares were bought by its insiders, resulting in a net purchase of 1,419,900 shares.
Knight Therapeutics Inc (TSX:GUD)'s detailed insider trading history can be found in Insider Trading Tracker table.
Knight Therapeutics Inc Insider Transactions
Robert Nathaniel Lande Mailing Address
Above is the net worth, insider trading, and ownership report for Robert Nathaniel Lande. Currently GuruFocus does not have mailing address information for Robert Nathaniel Lande.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
